May 03, 2019
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
RingJect delivery system receives US marketing approval
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
The FDA approved the RingJect with optimized delivery system enhancements, according to an Ophtec press release.
The single-use injector comes preloaded with the Ophtec capsular tension ring.
The RingJect can be used in premium IOL procedures for improved IOL centration and stabilization, the release said.